Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Cooper

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
JMIR Mental Health|January 15, 2021
Correction: Evaluation of a Mobile App to Enhance Relational Awareness and Change During Cognitive Analytic Therapy: Mixed Methods Case SeriesStephen Kellett, Katherine Easton, Martin Cooper, et al.
Surgical Endoscopy|December 11, 2008
Classification and early recognition of gastric conduit failure after minimally invasive esophagectomyDarmarajah Veeramootoo, Rajeev Parameswaran, Rakesh Krishnadas, et al.
Surgical Endoscopy|December 10, 2009
Ischemic conditioning shows a time-dependant influence on the fate of the gastric conduit after minimally invasive esophagectomyDarmarajah Veeramootoo, Angela C Shore, Beverley Shields, et al.
Bioorganic & Medicinal Chemistry Letters|December 4, 2009
Exploring SAR features in diverse library of 4-cyanomethyl-pyrazole-3-carboxamides suitable for further elaborations as CB1 antagonistsMartin Cooper, Jean-Marie Receveur, Emelie Bjurling, et al.
Bioorganic & Medicinal Chemistry Letters|December 3, 2023
Optimizing and characterizing 4-methyl substituted pyrazol-3-carboxamides leading to the peripheral cannabinoid 1 receptor inverse agonist TM38837Thomas Högberg, Jean-Marie Receveur, Anthony Murray, et al.
Bioorganic & Medicinal Chemistry Letters|December 18, 2009
Conversion of 4-cyanomethyl-pyrazole-3-carboxamides into CB1 antagonists with lowered propensity to pass the blood-brain-barrierJean-Marie Receveur, Anthony Murray, Jean-Michel Linget, et al.
Journal of Research of the National Institute of Standards and Technology|June 17, 2016
The Fundamental Neutron Physics Beamline at the Spallation Neutron SourceGeoffrey Greene, Vince Cianciolo, Paul Koehler, et al.
Journal of Medicinal Chemistry|December 5, 2025
Spirocyclopentane as a Novel Scaffold for Potent Ghrelin Receptor Full AgonistsCristina Gardelli, Antonio Llinas, Igor Shamovsky, et al.
Journal of Medicinal Chemistry|August 14, 2020
Identification and Optimization of Pyrrolidine Derivatives as Highly Potent Ghrelin Receptor Full AgonistsMartin Cooper, Antonio Llinas, Peter Hansen, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
JMIR Mental Health|January 15, 2021
Correction: Evaluation of a Mobile App to Enhance Relational Awareness and Change During Cognitive Analytic Therapy: Mixed Methods Case SeriesStephen Kellett, Katherine Easton, Martin Cooper, et al.
Surgical Endoscopy|December 11, 2008
Classification and early recognition of gastric conduit failure after minimally invasive esophagectomyDarmarajah Veeramootoo, Rajeev Parameswaran, Rakesh Krishnadas, et al.
Surgical Endoscopy|December 10, 2009
Ischemic conditioning shows a time-dependant influence on the fate of the gastric conduit after minimally invasive esophagectomyDarmarajah Veeramootoo, Angela C Shore, Beverley Shields, et al.
Bioorganic & Medicinal Chemistry Letters|December 4, 2009
Exploring SAR features in diverse library of 4-cyanomethyl-pyrazole-3-carboxamides suitable for further elaborations as CB1 antagonistsMartin Cooper, Jean-Marie Receveur, Emelie Bjurling, et al.
Bioorganic & Medicinal Chemistry Letters|December 3, 2023
Optimizing and characterizing 4-methyl substituted pyrazol-3-carboxamides leading to the peripheral cannabinoid 1 receptor inverse agonist TM38837Thomas Högberg, Jean-Marie Receveur, Anthony Murray, et al.
Bioorganic & Medicinal Chemistry Letters|December 18, 2009
Conversion of 4-cyanomethyl-pyrazole-3-carboxamides into CB1 antagonists with lowered propensity to pass the blood-brain-barrierJean-Marie Receveur, Anthony Murray, Jean-Michel Linget, et al.
Journal of Research of the National Institute of Standards and Technology|June 17, 2016
The Fundamental Neutron Physics Beamline at the Spallation Neutron SourceGeoffrey Greene, Vince Cianciolo, Paul Koehler, et al.
Journal of Medicinal Chemistry|December 5, 2025
Spirocyclopentane as a Novel Scaffold for Potent Ghrelin Receptor Full AgonistsCristina Gardelli, Antonio Llinas, Igor Shamovsky, et al.
Journal of Medicinal Chemistry|August 14, 2020
Identification and Optimization of Pyrrolidine Derivatives as Highly Potent Ghrelin Receptor Full AgonistsMartin Cooper, Antonio Llinas, Peter Hansen, et al.
Pageof 2